{"DataElement":{"publicId":"7429302","version":"1","preferredName":"Deauville Result","preferredDefinition":"Numeric score for the outcome of the London Deauville Criteria 5 Point Scale disease response assessment.","longName":"RSORRES_DEUVL","context":"Theradex","contextVersion":"1","DataElementConcept":{"publicId":"7429294","version":"1","preferredName":"Disease Response Domain Target Lesion London Deauville Criteria Point Scale Disease Response Original Result","preferredDefinition":"A domain for disease response evaluations._An object fixed as a goal or point of examination; something to point at; a destination._A localized pathological or traumatic structural change, damage, deformity, or discontinuity of tissue, organ, or body part._A 5 point scale devised to assess the response to treatment of Hodgkin and Aggressive Non-Hodgkin Lymphoma._The outcome of the disease response assessment as originally received or collected.","longName":"6608777v1.0:7429292v1.0","context":"Theradex","contextVersion":"1","ObjectClass":{"publicId":"6608777","version":"1","preferredName":"Disease Response Domain","preferredDefinition":"A domain for disease response evaluations.","longName":"C107097","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Disease Response Domain","conceptCode":"C107097","definition":"A domain for disease response evaluations.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"7F6DD03A-0CB9-71AE-E053-F662850AB42C","latestVersionIndicator":"Yes","beginDate":"2019-01-14","endDate":null,"createdBy":"TAYLORT","dateCreated":"2019-01-14","modifiedBy":"ONEDATA","dateModified":"2019-01-14","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"7429292","version":"1","preferredName":"Target Lesion London Deauville Criteria Point Scale Disease Response Original Result","preferredDefinition":"An object fixed as a goal or point of examination; something to point at; a destination.:A localized pathological or traumatic structural change, damage, deformity, or discontinuity of tissue, organ, or body part.:A 5 point scale devised to assess the response to treatment of Hodgkin and Aggressive Non-Hodgkin Lymphoma.:The outcome of the disease response assessment as originally received or collected.","longName":"C25702:C3824:C99723:C117397","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Target","conceptCode":"C25702","definition":"An object fixed as a goal or point of examination; something to point at; a destination.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"Lesion","conceptCode":"C3824","definition":"A localized pathological or traumatic structural change, damage, deformity, or discontinuity of tissue, organ, or body part.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"London Deauville Criteria Point Scale","conceptCode":"C99723","definition":"A 5 point scale devised to assess the response to treatment of Hodgkin and Aggressive Non-Hodgkin Lymphoma.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Disease Response Original Result","conceptCode":"C117397","definition":"The outcome of the disease response assessment as originally received or collected.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"AFD9C16A-1657-79BC-E053-4EBD850A5BB5","latestVersionIndicator":"Yes","beginDate":"2020-09-22","endDate":null,"createdBy":"TAYLORT","dateCreated":"2020-09-22","modifiedBy":"ONEDATA","dateModified":"2020-09-22","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008550","version":"1","preferredName":"Disease Response","preferredDefinition":"the response criteria (includes RECIST and others) and associated documentation of disease.","longName":"DZ_RESP","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B22C0651-216B-5273-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-19","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-19","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"AFD9C16A-1668-79BC-E053-4EBD850A5BB5","latestVersionIndicator":"Yes","beginDate":"2020-09-22","endDate":null,"createdBy":"TAYLORT","dateCreated":"2020-09-22","modifiedBy":"TAYLORT","dateModified":"2020-09-23","changeDescription":"PED-CITN-01 NSV; TL","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"7429298","version":"1","preferredName":"London Deauville Criteria Point Scale","preferredDefinition":"A 5 point scale devised to assess the response to treatment of Hodgkin and Aggressive Non-Hodgkin Lymphoma._An ordered reference standard used to measure incremental changes.","longName":"DEAUVL_SCALE","context":"Theradex","contextVersion":"1","type":"Enumerated","dataType":"NUMBER","minLength":"1","maxLength":"1","minValue":"1","maxValue":"5","decimalPlace":null,"PermissibleValues":[{"value":"1","valueDescription":"London Deauville Criteria Point Scale 1","ValueMeaning":{"publicId":"5597209","version":"1","preferredName":"London Deauville Criteria Point Scale 1","longName":"5597209","preferredDefinition":"The results of the positron emission tomography are negative; there is no detectable abnormal tracer uptake.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"London Deauville Criteria Point Scale 1","conceptCode":"C99728","definition":"The results of the positron emission tomography are negative; there is no detectable abnormal tracer uptake.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"43186B3B-51EC-15A1-E053-F662850AA463","latestVersionIndicator":"Yes","beginDate":"2016-12-07","endDate":null,"createdBy":"COOPERM","dateCreated":"2016-12-07","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"AFD9E056-D0F1-4475-E053-4EBD850AF22C","beginDate":"2016-12-07","endDate":null,"createdBy":"TAYLORT","dateCreated":"2020-09-22","modifiedBy":"ONEDATA","dateModified":"2020-09-22","deletedIndicator":"No"},{"value":"2","valueDescription":"London Deauville Criteria Point Scale 2","ValueMeaning":{"publicId":"5597210","version":"1","preferredName":"London Deauville Criteria Point Scale 2","longName":"5597210","preferredDefinition":"The results of the positron emission tomography are negative; the tracer uptake is less than or equal to the mediastinum.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"London Deauville Criteria Point Scale 2","conceptCode":"C99747","definition":"The results of the positron emission tomography are negative; the tracer uptake is less than or equal to the mediastinum.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"43186B3B-520F-15A1-E053-F662850AA463","latestVersionIndicator":"Yes","beginDate":"2016-12-07","endDate":null,"createdBy":"COOPERM","dateCreated":"2016-12-07","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"AFD9E056-D0FC-4475-E053-4EBD850AF22C","beginDate":"2016-12-07","endDate":null,"createdBy":"TAYLORT","dateCreated":"2020-09-22","modifiedBy":"ONEDATA","dateModified":"2020-09-22","deletedIndicator":"No"},{"value":"3","valueDescription":"London Deauville Criteria Point Scale 3","ValueMeaning":{"publicId":"5597211","version":"1","preferredName":"London Deauville Criteria Point Scale 3","longName":"5597211","preferredDefinition":"The results of the positron emission tomography are negative; the tracer uptake is greater than the mediastinum but less than or equal to the liver.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"London Deauville Criteria Point Scale 3","conceptCode":"C99748","definition":"The results of the positron emission tomography are negative; the tracer uptake is greater than the mediastinum but less than or equal to the liver.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"43186B3B-5232-15A1-E053-F662850AA463","latestVersionIndicator":"Yes","beginDate":"2016-12-07","endDate":null,"createdBy":"COOPERM","dateCreated":"2016-12-07","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"AFD9E056-D107-4475-E053-4EBD850AF22C","beginDate":"2016-12-07","endDate":null,"createdBy":"TAYLORT","dateCreated":"2020-09-22","modifiedBy":"ONEDATA","dateModified":"2020-09-22","deletedIndicator":"No"},{"value":"4","valueDescription":"London Deauville Criteria Point Scale 4","ValueMeaning":{"publicId":"5597212","version":"1","preferredName":"London Deauville Criteria Point Scale 4","longName":"5597212","preferredDefinition":"The results of the positron emission tomography are positive; the tracer uptake is moderately more than the liver uptake, at any disease site.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"London Deauville Criteria Point Scale 4","conceptCode":"C99749","definition":"The results of the positron emission tomography are positive; the tracer uptake is moderately more than the liver uptake, at any disease site.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"43186B3B-5255-15A1-E053-F662850AA463","latestVersionIndicator":"Yes","beginDate":"2016-12-07","endDate":null,"createdBy":"COOPERM","dateCreated":"2016-12-07","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"AFD9E056-D112-4475-E053-4EBD850AF22C","beginDate":"2016-12-07","endDate":null,"createdBy":"TAYLORT","dateCreated":"2020-09-22","modifiedBy":"ONEDATA","dateModified":"2020-09-22","deletedIndicator":"No"},{"value":"5","valueDescription":"London Deauville Criteria Point Scale 5","ValueMeaning":{"publicId":"5597213","version":"1","preferredName":"London Deauville Criteria Point Scale 5","longName":"5597213","preferredDefinition":"The results of the positron emission tomography are positive; the tracer uptake is markedly increased at any disease site.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"London Deauville Criteria Point Scale 5","conceptCode":"C99750","definition":"The results of the positron emission tomography are positive; the tracer uptake is markedly increased at any disease site.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"43186B3B-5278-15A1-E053-F662850AA463","latestVersionIndicator":"Yes","beginDate":"2016-12-07","endDate":null,"createdBy":"COOPERM","dateCreated":"2016-12-07","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"AFD9E056-D11D-4475-E053-4EBD850AF22C","beginDate":"2016-12-07","endDate":null,"createdBy":"TAYLORT","dateCreated":"2020-09-22","modifiedBy":"ONEDATA","dateModified":"2020-09-22","deletedIndicator":"No"},{"value":"X","valueDescription":"London Deauville Criteria Point Scale X","ValueMeaning":{"publicId":"5597208","version":"1","preferredName":"London Deauville Criteria Point Scale X","longName":"5597208","preferredDefinition":"New areas of uptake unlikely to be related to lymphoma.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"London Deauville Criteria Point Scale X","conceptCode":"C136879","definition":"New areas of uptake unlikely to be related to lymphoma.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"43186B3B-51C9-15A1-E053-F662850AA463","latestVersionIndicator":"Yes","beginDate":"2016-12-07","endDate":null,"createdBy":"COOPERM","dateCreated":"2016-12-07","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"B8A2E4C1-1D4D-03A5-E053-4EBD850AC4A3","beginDate":"2021-01-11","endDate":null,"createdBy":"SOKKERL","dateCreated":"2021-01-11","modifiedBy":"ONEDATA","dateModified":"2021-01-11","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008550","version":"1","preferredName":"Disease Response","preferredDefinition":"the response criteria (includes RECIST and others) and associated documentation of disease.","longName":"DZ_RESP","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B22C0651-216B-5273-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-19","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-19","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"7429297","version":"1","preferredName":"London Deauville Criteria Point Scale Scale","preferredDefinition":"A 5 point scale devised to assess the response to treatment of Hodgkin and Aggressive Non-Hodgkin Lymphoma.:An ordered reference standard used to measure incremental changes.","longName":"C99723:C25664","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"London Deauville Criteria Point Scale","conceptCode":"C99723","definition":"A 5 point scale devised to assess the response to treatment of Hodgkin and Aggressive Non-Hodgkin Lymphoma.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Scale","conceptCode":"C25664","definition":"An ordered reference standard used to measure incremental changes.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"AFD9E056-D0C7-4475-E053-4EBD850AF22C","latestVersionIndicator":"Yes","beginDate":"2020-09-22","endDate":null,"createdBy":"TAYLORT","dateCreated":"2020-09-22","modifiedBy":"ONEDATA","dateModified":"2020-09-22","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"Deauville Criteria:London Deauville Criteria Point Scale","workflowStatus":"RELEASED","registrationStatus":"Application","id":"AFD9E056-D0D8-4475-E053-4EBD850AF22C","latestVersionIndicator":"Yes","beginDate":"2020-09-22","endDate":null,"createdBy":"TAYLORT","dateCreated":"2020-09-22","modifiedBy":"SOKKERL","dateModified":"2021-01-11","changeDescription":"PED-CITN-01; TL.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"2961451","version":"1","longName":"Children's Oncology Group (COG)","context":"COG","ClassificationSchemeItems":[{"publicId":"2961452","version":"1","longName":"Statistics and Data Center","context":"COG"}]}],"AlternateNames":[{"name":"COG","type":"USED_BY","context":"COG"},{"name":"RS_RSORRES_DEUVL","type":"COG Form Element","context":"COG"}],"ReferenceDocuments":[{"name":"Deauville score","type":"Preferred Question Text","description":"Deauville score","url":null,"context":"Theradex"},{"name":"Theradex - 1","type":"Alternate Question Text","description":"If Yes, Deauville score","url":null,"context":"Theradex"},{"name":"COG CRF Text 1","type":"Alternate Question Text","description":"Overall Deauville score:","url":null,"context":"COG"},{"name":"COG CRF Text 2","type":"Alternate Question Text","description":"Deauville score:","url":null,"context":"COG"},{"name":"AMC CRF Text 1","type":"Alternate Question Text","description":"What was the most active number for the Deauville score?","url":null,"context":"AMC"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"AFD9DB6C-865E-7AF2-E053-4EBD850A88B8","latestVersionIndicator":"Yes","beginDate":"2020-09-22","endDate":null,"createdBy":"TAYLORT","dateCreated":"2020-09-22","modifiedBy":"TSESU","dateModified":"2023-08-28","changeDescription":"PED-CITN-01 NSV; TL.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}